Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 2 | VINDECA LIFE SCIENCES PRIVATE LIMITED | Awarded | 1 | ₹12,096 |
| 2 | Schedule 3 | ARORA BROS MEDILINKERS | Awarded | 1 | ₹23,283 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 Jun 2024, 5:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
ETHAMBUTOL 800 MG TAb
PAROXETIN 25 MG TAB
TICAGRELOR 60 MG TAB
6428922
GEM/2024/B/4967794
Two Packet Bid
ETHAMBUTOL 800 MG TAb,PAROXETIN 25 MG TAB,TICAGRELOR 60 MG TAB
15 days
Delhi; New Delhi
Item wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
10%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| ETHAMBUTOL 800 MG TAb | NEW DELHI | 8,700 | 15 days | |
| PAROXETIN 25 MG TAB | NEW DELHI | 4,800 | 15 days | |
| TICAGRELOR 60 MG TAB | NEW DELHI | 3,900 | 15 days |
Exempted
11 Jun 2024
21 May 2024
11 Jun 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6428922.pdf
GEM_BID
79med_2024-05-21-15-49-19_985eeb734d3a77051d37c21e25d2c7de.pdf
SPECIFICATION
79med_2024-05-21-15-49-53_87ff5fe47b89bdaadf0082dcba02b097.pdf
SPECIFICATION
79med_2024-05-21-15-50-26_a5a277276a7c3a2603078a0b7a4693fd.pdf
SPECIFICATION
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .